Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aberrant expression of ALK and EZH2 in Merkel cell carcinoma

31 Mar 2017

Abstract excerpt

BACKGROUND: Distinct characteristic features categorize Merkel cell carcinoma (MCC) into two subgroups according to the Merkel cell polyomavirus infection. Many mutational studies on MCC have been carried out in recent years without identifying a prominent driver mutation. However, there is paucity reporting the expression of cancer genes at the RNA level in MCC tumors. In this study, we studied the RNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Infectious Encephalopathies and Encephalitis
Share to Polyomavirus and related diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28359267
DOI: 10.1186/s12885-017-3233-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aberrant expression of ALK and EZH2 in Merkel cell carcinomaPMID 28359267Read ↗

Mutational Analysis of Merkel Cell CarcinomaSemantic proximity Read ↗

Update on Merkel Cell Carcinoma.Semantic proximity Read ↗

Merkel cell carcinoma: an updated overview of clinico-pathological aspects, molecular genetics and therapy.Semantic proximity Read ↗

miRNAs driving diagnosis, prognosis and progression in Merkel cell carcinomaSemantic proximity Read ↗

Danger is only skin deep: aggressive epidermal carcinomas. An overview of the diagnosis, demographics, molecular-genetics, staging, prognostic biomarkers, and therapeutic advances in Merkel cell carcinoma.Semantic proximity Read ↗

Merkel Cell Carcinoma from Molecular Pathology to Novel TherapiesSemantic proximity Read ↗

Transcriptomic analyses reveal three distinct molecular subgroups of Merkel cell carcinoma with differing prognosesSemantic proximity Read ↗

Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.Semantic proximity Read ↗

Molecular Pathogenesis of Merkel Cell Carcinoma.Semantic proximity Read ↗

Merkel cell carcinoma.Semantic proximity Read ↗

Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinomaSemantic proximity Read ↗

LT and SOX9 expression are associated with gene sets that distinguish Merkel cell polyomavirus (MCPyV)-positive and MCPyV-negative Merkel cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.